Elena de Benavides (Climbcrew)

Asturias
September 11, 2015 / 7:00 PM

About this event

CEO of Climbcrew, Startups accelerator owned by Amber Capital and Expansion Group. In Climbcrew, they start from business ideas where unite, technology, capital and human resources to make them successful startups. They were able to raise 2.8 million to carry out the project, which in its first year of operation, has already created six startups, one of which has been sold to another player in the sector, two have completed their first round and the third one will start the second round in the last quarter. Before leading the project that unites everyday vision of the investor and the entrepreneur in a single business model, Elena was Director of Operations of the Amber Group. But his entrepreneurial restlessness years ago began with several experiences of entrepreneurship before adulthood, and as CEO of IIDF, biotech sector Startup, which created the first injectable foam drug approved by the FDA, and that received the award TR35 MIT in 2011. She currently serves on the Investment Committee Vivergi Social Impact Fund, providing expertise in the healthcare sector and biotech, and advisor of several technology startups.

Speaker

Elena de Benavides (Climbcrew)

Elena de Benavides

Climbcrew

CEO of Climbcrew, Startups accelerator owned by Amber Capital and Expansion Group. In Climbcrew, they start from business ideas where unite, technology, capital and human resources to make them successful startups. They were able to raise 2.8 million to carry out the project, which in its first year of operation, has already created six startups, one of which has been sold to another player in the sector, two have completed their first round and the third one will start the second round in the last quarter. Before leading the project that unites everyday vision of the investor and the entrepreneur in a single business model, Elena was Director of Operations of the Amber Group. But his entrepreneurial restlessness years ago began with several experiences of entrepreneurship before adulthood, and as CEO of IIDF, biotech sector Startup, which created the first injectable foam drug approved by the FDA, and that received the award TR35 MIT in 2011. She currently serves on the Investment Committee Vivergi Social Impact Fund, providing expertise in the healthcare sector and biotech, and advisor of several technology startups.

Date and Time
September 11, 2015
7:00 PM - 10:00 PM
 
Address

Centro Niemeyer
Avenida del Zinc, s/n
33400 Avilés

 
Agenda
07:00 PM Networking and Food
08:00 PM Fireside Chat
09:00 PM Networking
 

Brought to you by

Local Sponsors

We are Startup Grind